Frederick Shainfeld, former senior vice president at Halsey Drug of the USA, has been sentenced to 18 months in prison and ordered to pay a $5,000 fine after pleading guilty last year to obstructing a US Food and Drug Administration inspection of the pharmaceutical company.
He and four other Halsey executives were indicted in 1993 for conspiracy to impede FDA regulatory function, interstate distribution of adulterated and unapproved new drugs, making false statements and obstructing an FDA inspection.
The Justice Department said Mr Shainfeld admitted that he and others faked records that misrepresented batch sizes required by the agency to ensure a company can make production quantities of a drug.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze